The distribution of lipoprotein lipase in rat adipose tissue. Changes with nutritional state engage the extracellular enzyme.
Lipoprotein lipase (LPL) acts at the vascular endothelium. Earlier studies have shown that down-regulation of adipose tissue LPL during fasting is post-translational and involves a shift from active to inactive forms of the lipase. Studies in cell systems had indicated that during fasting LPL might be retained in the endoplasmic reticulum. We have now explored the relation between active/inactive and intra/extracellular forms of the lipase. Within adipocytes, neither LPL mass nor the distribution of LPL between active and inactive forms changed on fasting. Extracellular LPL mass also did not change significantly, but shifted from predominantly active to predominantly inactive. To explore if changes in secretion were compensated by changes in turnover, synthesis of new protein was blocked by cycloheximide. The rates at which intra- and extracellular LPL mass and activity decreased did not change on fasting. To further explore how LPL is distributed in the tissue, heparin (which detaches the enzyme from the endothelial surface) was injected. Tissue LPL activity decreased by about 10% in 2 min and by 50% in 1 h. Heparin released mainly the active form of the lipase. There was no change of LPL activity or mass within adipocytes. The fraction of extracellular LPL that heparin released and the time course were the same in fed and fasted rats, indicating that active, extracellular LPL was distributed in a similar way in the two nutritional states. This study suggests that the nutritional regulation of LPL in adipose tissue determines the activity state of extracellular LPL.
Wu
Gengshu
G
Department of Medical Biosciences, Physiological Chemistry, Umeå University, SE-90185 Umeå, Sweden.
Olivecrona
Gunilla
G
Olivecrona
Thomas
T
D017667:Adipocytes / Q000201:enzymology; D000273:Adipose Tissue / Q000166:cytology / Q000201:enzymology*; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004435:Eating; D004789:Enzyme Activation; D005110:Extracellular Space / Q000201:enzymology; D006493:Heparin / Q000494:pharmacology; D008071:Lipoprotein Lipase / Q000032:analysis*; D008297:Male; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000925:Anticoagulants; D011500:Protein Synthesis Inhibitors; D006493:Heparin; D003513:Cycloheximide; D008071:Lipoprotein Lipase